# Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin

> **NCT00437320** · PHASE2 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 32 (actual)

## Conditions studied

- Photoaged Skin

## Interventions

- **DRUG:** Metvix Cream 160 mg/g
- **DRUG:** Metvix Vehicle Group

## Key facts

- **NCT ID:** NCT00437320
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04-18
- **Primary completion:** 2008-09-01
- **Final completion:** 2008-09-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437320, "Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00437320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*